RESVERATROL MARKET ANALYSIS

Resveratrol Market - Insights

Resveratrol is a flavonol belonging to the group of flavonoids. It is a phytoalexin synthesized naturally by various plants when attacked by various pathogens such as bacteria or fungi. Resveratrol is present in different plants and fruits such as red grapes, peanuts, blueberries, mulberries, raspberries, eucalyptus, spruce, and others. Resveratrol is extensively used in pharmaceutical, cosmetic, and dietary supplement applications.

Resveratrol is widely applicable in pharmaceutical industry as it possesses properties to heal and manage various diseases such as cancer, cardio-vascular disease, diabetes, and neurological diseases. In cosmetic and dietary supplements industries, the popularity of antioxidants and its usage has increased drastically. Resveratrol is considered as a potent antioxidant, which makes it a unique candidate to provide desirable anti-aging effects in cosmetics and may have various beneficial effects when taken as dietary supplement such as reducing the chances of cardio-vascular disease and others.

Application of Resveratrol in Cosmetics and Dietary Supplements is Expected to Significantly Support Market Growth

Global cosmetic industry is witnessing robust growth and is expected to expand in the near future. This is due to increasing awareness of skincare among the population. The application of resveratrol in cosmetic industry is expected to drive global resveratrol market growth during the forecast period. Various key players launched its novel skincare products containing resveratrol, as an active ingredient.

For instance, in 2014, SkinCeuticals, a company involved in development of skincare products, expanded its resveratrol portfolio, with launch of Resveratrol B E, an antioxidant night concentrate, which drives skin's internal antioxidant defense system and helps to heal and reduce skin damages. Resveratrol B E contains a maximized concentration of 1% pure soluble resveratrol synergistically enhanced with baicalin and vitamin E for extra antioxidant protection. Launches of such novel products are expected to support growth of global resveratrol market during the forecast period.

Approvals and launches of novel resveratrol-based food and dietary supplements are expected to support growth of the global resveratrol market. For instance, in 2016, DSM Nutritional Products received European Union (EU) novel foods approval for resVida, a high purity trans-resveratrol, used in food supplements in capsule or tablet form, at doses of up to 150 mg per day.

The global resveratrol market size was valued at US$ 69.1 Mn in 2017, and is expected to witness a CAGR of 9.7% during the forecast period (2018 – 2026).

Asia Pacific is expected to be a potential growth region for resveratrol market during the forecast period, owing to positive decisions by regulatory bodies towards adoption of resveratrol, which will support growth of the market. For instance, in 2013, Japanese Ministry of Health, Labor and Welfare following request of Evolva Holding SA, issued a notice that resveratrol should be classified into ‘non-drug’ material group. This decision is expected to significantly enhance the accessibility for the products in Japan. Such decisions by regulatory bodies are expected to significantly drive growth of Asia Pacific resveratrol market during the forecast period.

Furthermore, Europe resveratrol market is expected to show good growth during the forecast period, owing to strategic mergers and acquisitions by key players to widen its product portfolio with resveratrol-based products. For instance, in 2012, Evolva SA, a Switzerland-based biotech firm, acquired Fluxom A/S resveratrol business for US$ 713,103 (€ 550,000).

Figure 1. Global Resveratrol Market Share (%), By Region, 2026

To learn more about this report, request sample copy

Source: Coherent Market Insights Analysis (2018)

Some side effects related with resveratrol is expected to hinder growth of the global resveratrol market during the forecast period. For instance, according to data published by National Institute of Health (NIH) in May 2018, resveratrol may cause side effects such as gastrointestinal upset, nausea, headache, and fatigue. It may also causes supplement-drug interactions with estrogens and anticoagulants, which is further expected to hinder its adoption.

Key players operating in the global resveratrol market include SkinCeuticals, Evolva SA, DSM Nutritionals, Jeunesse Global, VitaMonk, Helix Healthstore, Terraternal, Andorra Life, ResVitale, LLC, Endurance Products Company, RevGenetics, SiChuan Xieli Pharmaceutical Co., Ltd., and others.